The molecular march of primary and recurrent nasopharyngeal carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The molecular march of primary and recurrent nasopharyngeal carcinoma
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-22
DOI
10.1038/s41388-020-01631-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein‐Barr virus‐encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan‐2 and synaptotagmin‐like‐4 in nasopharyngeal carcinoma cells
- (2020) Chaoliang Liao et al. CANCER SCIENCE
- Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
- (2020) Yu-Pei Chen et al. CELL RESEARCH
- DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients
- (2020) Zeng-hong Wu et al. MEDICINE
- Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
- (2020) Shanzhao Jin et al. CELL RESEARCH
- Epstein–Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression
- (2019) Shiyue Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma
- (2019) Jun Zhang et al. ONCOGENE
- The next decade of clinical trials in locoregionally advanced nasopharyngeal carcinoma
- (2019) Liang Peng et al. BRITISH JOURNAL OF RADIOLOGY
- Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway
- (2019) Yuan-Ji Xu et al. CANCER LETTERS
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway
- (2019) An-Ko Chung et al. Cancer Medicine
- EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway
- (2019) Xiaohan Zhou et al. BIOSCIENCE REPORTS
- Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma
- (2019) Rui You et al. CANCER RESEARCH
- Translational genomics of nasopharyngeal cancer
- (2019) Chi Man Tsang et al. SEMINARS IN CANCER BIOLOGY
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma
- (2018) Raymond W-M Lung et al. JOURNAL OF PATHOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma
- (2018) Xiaoming Lyu et al. PLoS Pathogens
- BART miRNAs
- (2017) Youhong Wang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
- (2017) Li Zhang et al. MOLECULAR CANCER RESEARCH
- Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism
- (2017) Chao Wang et al. ONCOLOGY REPORTS
- The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism
- (2017) Lei Chen et al. OncoTargets and Therapy
- lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma
- (2017) Guo-Hui Nie et al. Oncology Letters
- Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
- (2017) Yvonne Y Li et al. Nature Communications
- PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes
- (2017) Yajuan Zhou et al. Oncotarget
- PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
- (2017) Yajuan Zhou et al. Scientific Reports
- Expression and Clinical Significance of Epidermal Growth Factor Receptor and Type 1 Insulin-Like Growth Factor Receptor in Nasopharyngeal Carcinoma
- (2017) Yulin Yuan et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
- (2017) Yock Ping Chow et al. Scientific Reports
- The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
- (2017) Tseng-Cheng Chen et al. Scientific Reports
- Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal
- (2016) Hugo Sousa et al. IMMUNOBIOLOGY
- Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression
- (2016) Y Pan et al. ONCOGENE
- Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma
- (2016) Shuling Ren et al. ONCOLOGY REPORTS
- Whole-exome sequencing identifiesMST1Ras a genetic susceptibility gene in nasopharyngeal carcinoma
- (2016) Wei Dai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
- (2016) Hong Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma
- (2016) Wen-Feng Hua et al. Cell Death & Disease
- Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1
- (2016) Yali Song et al. Oncotarget
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer
- (2016) Ran Zhao et al. EBioMedicine
- Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway
- (2015) Yumei Duan et al. CANCER LETTERS
- Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
- (2015) B. B. Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Nasopharyngeal Cancer: Molecular Landscape
- (2015) Jeff P. Bruce et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of MEF2B , EBF1 , and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival
- (2015) Italo Tempera et al. JOURNAL OF VIROLOGY
- EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop
- (2015) C-F Yang et al. ONCOGENE
- Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma
- (2015) TAO XU et al. ONCOLOGY REPORTS
- EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
- (2015) Zhi Li et al. Oncotarget
- Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma
- (2015) Wei Dai et al. Cancer Medicine
- Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients
- (2015) Yong Shen et al. Emerging Microbes & Infections
- Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
- (2015) Jiang Li et al. OncoImmunology
- The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
- (2015) Chi Man Tsang et al. VIROLOGICA SINICA
- Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma
- (2014) Li Yuan et al. CANCER BIOLOGY & THERAPY
- Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation
- (2014) S. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma
- (2014) NING JIANG et al. ONCOLOGY REPORTS
- Epstein-Barr Virus-Encoded Small RNAs (EBERs) Are Present in Fractions Related to Exosomes Released by EBV-Transformed Cells
- (2014) Waqar Ahmed et al. PLoS One
- Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy
- (2013) Cui Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differential miRNA expression in repeated recurrence of nasopharyngeal carcinoma
- (2013) Ling-Jung Wang et al. CANCER LETTERS
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- Long non-coding RNAHOTAIRis an independent prognostic marker for nasopharyngeal carcinoma progression and survival
- (2013) Yan Nie et al. CANCER SCIENCE
- Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge
- (2013) Tao Xu et al. Current Oncology
- Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein–Barr virus associated nasopharyngeal carcinoma
- (2013) Mark Fogg et al. VIROLOGY
- c-Myc and EBV–LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells
- (2012) C S Tudor et al. BRITISH JOURNAL OF CANCER
- Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
- (2012) Y Pan et al. ONCOGENE
- Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
- (2012) C. M. Tsang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
- (2012) Christopher W. Dawson et al. SEMINARS IN CANCER BIOLOGY
- Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
- (2011) O. A. Odumade et al. CLINICAL MICROBIOLOGY REVIEWS
- Epstein-Barr Virus LMP1 Activates EGFR, STAT3, and ERK through Effects on PKC
- (2011) C.-P. Kung et al. JOURNAL OF VIROLOGY
- Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98
- (2011) N M Alajez et al. Cell Death & Disease
- Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population
- (2010) M Tang et al. GENES AND IMMUNITY
- Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency
- (2010) Hisashi Iizasa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation
- (2009) K M Shah et al. ONCOGENE
- Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
- (2007) R. E. Randall et al. JOURNAL OF GENERAL VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now